A topical cream formulation of the JAK inhibitor ruxolitinib was superior to its vehicle for treating vitiligo across all primary and secondary endpoints in two multicenter phase 3 trials presented ...

Winnie Harlow has been in the news this week, owning the red carpet at Haute Couture week in Paris. The 22-year-old Canadian model has vitiligo, which has given her distinctive white patches on her ...

Favorable outcomes were observed among patients with vitiligo who received systemic Janus kinase inhibitors, with tofacitinib associated with the highest rate of complete resolution. Tofacitinib may ...

This article is sponsored by Incyte. Vitiligo is a chronic autoimmune condition that manifests as white patches of depigmented skin, or a complete loss of color, on affected areas of the body. The ...

Vitiligo is a long-lasting condition that causes a loss of color in patches on the skin. It happens when the body's immune system mistakenly attacks and destroys the skin cells that make color or ...

Vitiligo is a skin condition that causes areas of the skin to lose color or pigmentation. It’s not contagious and can occur on any part of the body. About 1.4% of adults in the United States have been ...

Ruxolitinib has been called a miracle cream - but it can also carry severe side-effects A controversial new cream used to treat vitiligo could soon become available on the NHS. In trials, Ruxolitinib ...

The skin condition vitiligo causes people to lose pigment in patches of skin in different areas of their body. In many cases, these light or white areas of skin are the only symptom of vitiligo.

A controversial new cream used to treat vitiligo could soon become available on the NHS. In trials, Ruxolitinib - which carries the brand name Opzelura - was an effective treatment, but also carries ...